Carbetocin Impurity 4 is a structurally related peptide species generated during carbetocin synthesis or storage. Variations in side-chain or ring connectivity influence folding and chromatographic behavior. Researchers characterize it using LC-MS and NMR to ensure method selectivity. Applications include process-control support, impurity-specification definition, and structure-purity correlation.
CAT No: Z10-101-207
Synonyms/Alias:2-((3R,6S,9S,12S,15S)-3-((S)-2-(((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-9-(3-amino-3-oxopropyl)-12-((S)-sec-butyl)-15-(4-methoxybenzyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacycloicosan-6-yl)acetic acid
Carbetocin Impurity 4 is a specialized carbohydrate compound frequently encountered in the quality assessment and research of synthetic oxytocin analogs. As an identifiable side product formed during the synthesis of carbetocin, it possesses a unique molecular structure that distinguishes it from the parent molecule and other related impurities. Its availability as a reference standard supports a wide array of investigative and analytical processes, particularly in pharmaceutical development and peptide chemistry. Researchers value its well-characterized properties, which enable precise quantification and detection in complex mixtures. The compound's distinct chromatographic and spectroscopic signatures provide a reliable means for laboratories to validate analytical methods and ensure the integrity of their results. Carbetocin Impurity 4 thus plays a significant role in the broader context of peptide research, offering insights into synthetic pathways, degradation mechanisms, and the optimization of manufacturing processes.
Analytical Method Development: Carbetocin Impurity 4 is essential in the development and validation of analytical methods for peptide-based drugs. By incorporating this impurity as a reference material in high-performance liquid chromatography (HPLC) or mass spectrometry (MS) protocols, scientists can accurately assess the specificity, sensitivity, and robustness of their detection techniques. Its presence allows the calibration of analytical instruments, ensuring that even trace levels of related substances in synthetic carbetocin preparations are reliably identified and quantified. This, in turn, supports the establishment of consistent quality control procedures across research and manufacturing environments.
Process Optimization: In the context of process optimization, the identification and quantification of Carbetocin Impurity 4 provide critical feedback on synthetic protocols. By monitoring the formation of this impurity during peptide synthesis, chemists can adjust reaction conditions, purification strategies, and reagent selections to minimize its occurrence. This iterative approach leads to higher yields of the desired product and reduces the need for extensive downstream purification. Understanding the pathways that give rise to this specific impurity also aids in troubleshooting and refining manufacturing processes, ultimately contributing to more efficient and cost-effective peptide production.
Degradation Studies: Carbetocin Impurity 4 serves as a valuable marker in degradation studies of carbetocin and its analogs. Researchers utilize its unique profile to investigate the stability of peptide formulations under various environmental conditions, such as temperature, humidity, and light exposure. By tracking the appearance and concentration changes of this impurity over time, scientists gain insights into the degradation mechanisms that may affect product shelf life and storage requirements. These studies inform the development of more stable formulations and packaging solutions, enhancing the overall reliability of peptide therapeutics in research settings.
Reference Standard in Comparative Studies: As a reference standard, Carbetocin Impurity 4 is instrumental in comparative studies evaluating the impurity profiles of different carbetocin batches or synthetic routes. By providing a consistent benchmark, it enables researchers to assess batch-to-batch variability and the impact of process modifications on impurity formation. This comparative analysis is crucial for ensuring reproducibility and quality in peptide synthesis, as well as for supporting the documentation required for research publications and technical reports.
Peptide Mapping and Structural Elucidation: The unique structure of Carbetocin Impurity 4 offers opportunities for peptide mapping and structural elucidation studies. Scientists employ advanced spectroscopic techniques, such as nuclear magnetic resonance (NMR) and tandem mass spectrometry, to characterize its molecular features and differentiate it from other related compounds. These investigations deepen the understanding of peptide fragmentation patterns, isomerization events, and side reactions that may occur during synthesis. The insights gained from such studies not only enhance the knowledge base surrounding carbetocin chemistry but also inform the design of more selective and efficient synthetic routes for future peptide analogs.
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.